Turing Pharmaceuticals AG
www.turingpharma.com
Latest From Turing Pharmaceuticals AG
FDA Approves First Generic Of Daraprim
Daraprim, which saw its price jacked up by 4,000% by former drug company executive Martin Shkreli, now has a competitor with the US Food and Drug Administration’s approval of the first generic version of the nearly seven-decade-old drug used to treat a life-threatening parasitic infection known as toxoplasmosis.
The ‘Re-Pricer’ Reckoning: Makena, Daraprim And Acthar Under Pressure
The controversies have shown that, while it may be easy to scapegoat outliers, it is remarkably hard to lower a drug price by political fiat. It took a while, but now Makena, Daraprim and Acthar are all facing very different days of reckoning.
Pharma Enforcement Remains 'Priority Area' In FTC's 2021 Budget Request
US Federal Trade Commission has mainly focused in pay-for-delay cases over the past decade, but pricing strategies are an emerging area of attention; industry is paying close attention to potential enforcement in biosimilar market.
Daraprim Drug Pricing Suit Against Shkreli And Vyera May Signal Future FTC Actions
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Nasal
- Specialty Pharmaceuticals
-
Drug Delivery
- Therapeutic Areas
- Cardiovascular
- Gynecological, Urological
- Infectious & Viral Diseases
- Neurology, Nervous System
- Alias(es)
- Turing Pharmaceuticals LLC
- Turing Pharmaceuticals LLC
- Turing Pharmaceuticals LLC
- Ownership
- Private
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Switzerland
-
Switzerland
-
Western Europe
-
Europe
- Parent & Subsidiaries
- Turing Pharmaceuticals AG
- Senior Management
-
Ron Tilles, Interim CEO
Nancy Retzlaff, Chief Commercial Officer
Eliseo Oreste Salinas, MD, Pres., R&D - Contact Info
-
Turing Pharmaceuticals AG
Phone: 41 760 24 24
Haldenstrasse 5
Baar, NY CH-6340
Switzerland